📣 VC round data is live. Check it out!

Dallah Healthcare Valuation Multiples

Discover revenue and EBITDA valuation multiples for Dallah Healthcare and similar public comparables like IKS Health, LifeStance Health, Option Care Health, Concentra Group and more.

Dallah Healthcare Overview

About Dallah Healthcare

Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing and maintaining the healthcare entities, wholesale medicines and retail of medical and surgical equipment, prosthetics and devices for the disabled, hospital equipment and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants and the packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Services/Medicine and Pharmaceutical products. The majority of the company's revenue is earned from the Medical service segment.


Founded

1994

HQ

Saudi Arabia

Employees

N/A

Financials (LTM)

Revenue: $1B
EBITDA: $237M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Dallah Healthcare Financials

Dallah Healthcare reported last 12-month revenue of $1B and EBITDA of $237M.

In the same LTM period, Dallah Healthcare generated $397M in gross profit, $237M in EBITDA, and $148M in net income.

Revenue (LTM)


Dallah Healthcare P&L

In the most recent fiscal year, Dallah Healthcare reported revenue of $861M and EBITDA of $202M.

Dallah Healthcare is profitable as of last fiscal year, with gross margin of 38%, EBITDA margin of 23%, and net margin of 15%.

See analyst estimates for Dallah Healthcare
LTMLast FY202320242025202620272028
Revenue$1B$861M$790M$861M$1B
Gross Profit$397M$324M$290M$324M$387M
Gross Margin35%38%37%38%36%
EBITDA$237M$202M$169M$202M$227M
EBITDA Margin21%23%21%23%21%
EBIT Margin16%18%18%18%16%
Net Profit$148M$127M$97M$127M$141M
Net Margin13%15%12%15%13%
Net Debt—$465M———

Financial data powered by Morningstar, Inc.

Dallah Healthcare Stock Performance

Dallah Healthcare has current market cap of $3B, and enterprise value of $4B.

Market Cap Evolution


Dallah Healthcare's stock price is $30.07.

Dallah Healthcare share price decreased by 9.4% in the last 30 days, and by 4.9% in the last year.

Dallah Healthcare has an EPS (earnings per share) of $1.25.

See more trading valuation data for Dallah Healthcare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$3B-3.1%-9.4%12.9%-4.9%$1.25

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Dallah Healthcare Valuation Multiples

Dallah Healthcare trades at 3.5x EV/Revenue multiple, and 16.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Dallah Healthcare

EV / Revenue (LTM)


Dallah Healthcare Financial Valuation Multiples

As of May 13, 2026, Dallah Healthcare has market cap of $3B and EV of $4B.

Dallah Healthcare has a P/E ratio of 20.6x.

LTMLast FY202320242025202620272028
EV/Revenue3.5x4.5x4.9x4.5x3.6x
EV/EBITDA16.5x19.4x23.1x19.4x17.2x
EV/EBIT22.0x24.8x28.1x24.8x23.2x
EV/Gross Profit9.8x12.0x13.5x12.0x10.1x
P/E20.6x24.0x31.4x24.0x21.6x
EV/FCFn/m46.4x44.1x46.4xn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Dallah Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Dallah Healthcare Margins & Growth Rates

Dallah Healthcare grew revenue by 26% and EBITDA by 13% in the last fiscal year.

In the most recent fiscal year, Dallah Healthcare reported gross margin of 38%, EBITDA margin of 23%, and net margin of 15%.

See estimated margins and future growth rates for Dallah Healthcare

Dallah Healthcare Margins

Last FY202420252026202720282029
Gross Margin38%38%36%34%
EBITDA Margin23%23%21%21%
EBIT Margin18%18%16%16%
Net Margin15%15%13%13%
FCF Margin10%10%(1%)1%

Dallah Healthcare Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth26%9%26%12%
Gross Profit Growth19%12%19%7%
EBITDA Growth13%19%13%11%
EBIT Growth7%13%7%15%
Net Profit Growth11%31%11%14%
FCF Growth(112%)(5%)(112%)(186%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Dallah Healthcare Operational KPIs

Dallah Healthcare's Rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Dallah Healthcare's Rule of X is 51% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Dallah Healthcare
LTMLast FY202320242025202620272028
Rule of 4032%33%———
Bessemer Rule of X48%51%———
S&M Expenses to Revenue3%2%2%2%3%
G&A Expenses to Revenue18%4%4%4%18%
Opex to Revenue—19%19%19%—

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Dallah Healthcare Competitors

Dallah Healthcare competitors include IKS Health, LifeStance Health, Option Care Health, Concentra Group, Medicover, Krishna Institute, Topchoice Medical, Asker Healthcare Group, Global Health and Mouwasat.

Most Dallah Healthcare public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
IKS Health11.1x8.9x36.7x26.9x
LifeStance Health2.3x2.1x20.5x18.4x
Option Care Health0.7x0.7x8.9x8.9x
Concentra Group2.4x2.4x12.2x11.8x
Medicover1.7x1.7x10.7x10.2x
Krishna Institute10.2x8.6x39.5x40.9x
Topchoice Medical6.6x6.3x20.4x20.8x
Asker Healthcare Group2.1x2.0x17.3x16.4x

This data is available for Pro users. Sign up to see all Dallah Healthcare competitors and their valuation data.

Start Free Trial

Dallah Healthcare M&A Activity

Dallah Healthcare has acquired 2 companies to date.

Last acquisition by Dallah Healthcare was on August 20th 2024. Dallah Healthcare acquired Al Salam International Hospital for $68M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Dallah Healthcare

Al Salam International Hospital
Al-Ahsa Medical Services
Description
—
—
HQ CountryKuwaitSaudi Arabia
HQ City
—
—
Deal Date20 Aug 202420 Aug 2024
Valuation$68M$114M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Dallah Healthcare acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Dallah Healthcare

When was Dallah Healthcare founded?Dallah Healthcare was founded in 1994.
Where is Dallah Healthcare headquartered?Dallah Healthcare is headquartered in Saudi Arabia.
Is Dallah Healthcare publicly listed?Yes, Dallah Healthcare is a public company listed on Tadawul.
What is the stock symbol of Dallah Healthcare?Dallah Healthcare trades under 4004 ticker.
When did Dallah Healthcare go public?Dallah Healthcare went public in 2012.
Who are competitors of Dallah Healthcare?Dallah Healthcare main competitors include IKS Health, LifeStance Health, Option Care Health, Concentra Group, Medicover, Krishna Institute, Topchoice Medical, Asker Healthcare Group, Global Health, Mouwasat.
What is the current market cap of Dallah Healthcare?Dallah Healthcare's current market cap is $3B.
What is the current revenue of Dallah Healthcare?Dallah Healthcare's last 12 months revenue is $1B.
What is the current revenue growth of Dallah Healthcare?Dallah Healthcare revenue growth (NTM/LTM) is 11%.
What is the current EV/Revenue multiple of Dallah Healthcare?Current revenue multiple of Dallah Healthcare is 3.5x.
Is Dallah Healthcare profitable?Yes, Dallah Healthcare is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Dallah Healthcare?Dallah Healthcare's last 12 months EBITDA is $237M.
What is Dallah Healthcare's EBITDA margin?Dallah Healthcare's last 12 months EBITDA margin is 21%.
What is the current EV/EBITDA multiple of Dallah Healthcare?Current EBITDA multiple of Dallah Healthcare is 16.5x.
What is the current FCF of Dallah Healthcare?Dallah Healthcare's last 12 months FCF is ($3M).
What is Dallah Healthcare's FCF margin?Dallah Healthcare's last 12 months FCF margin is (0%).
What is the current EV/FCF multiple of Dallah Healthcare?Current FCF multiple of Dallah Healthcare is (1133.1x).
How many companies Dallah Healthcare has acquired to date?As of May 2026, Dallah Healthcare has acquired 2 companies.
What was the largest acquisition by Dallah Healthcare?$114M acquisition of Al-Ahsa Medical Services on 20th August 2024 was the largest M&A Dallah Healthcare has done to date.
What companies Dallah Healthcare acquired?Dallah Healthcare acquired Al-Ahsa Medical Services and Al Salam International Hospital.
In how many companies Dallah Healthcare has invested to date?Dallah Healthcare hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Dallah Healthcare

Lists including Dallah Healthcare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial